Search for: "State v. Tri-State Pharmaceutical"
Results 361 - 380
of 455
Sorted by Relevance
|
Sort by Date
15 Sep 2011, 11:58 am
That abuse was at the heart of the case Kelo v. [read post]
5 Dec 2009, 3:21 am
Thus Hopper v. [read post]
2 Jun 2020, 10:35 am
Federal and State Prosecutions against Physicians and Screening Companies After Judge Jack’s exposé of fraudulent and false diagnoses in the silicosis MDL, various news media reported that the United States Attorney’s office in the Southern District of New York was investigating possible criminal charges against the physicians and lawyers who orchestrated the screenings. [read post]
23 Jul 2012, 4:37 am
EP2P displays not only that data but also the identity of the Internet Service Provider (ISP) and the city and state associated with the IP address sharing a particular file. [read post]
17 Jan 2008, 7:55 am
Liggett Group, Inc., 505 U.S. 504 (1992) (holding that state common law torts were something that was subject to preemption), Medtronic, Inc. v. [read post]
4 Mar 2012, 9:02 am
” Giles v. [read post]
23 Sep 2011, 12:08 pm
But, from a legal standpoint, the presence of medical device sales reps in the OR raises issues of proximity and temporality that are not typical in a pharmaceutical case (although there have been cases in which plaintiffs have tried to argue that a pharmaceutical representative should be held to an affirmative duty to take action. [read post]
27 May 2015, 7:00 am
Co. v. 23andMe, Inc., 2015 U.S. [read post]
27 Feb 2015, 4:58 am
Ironically, one of the cases cited for “these standards” was Carrera v. [read post]
3 Nov 2011, 7:52 am
Novartis Pharmaceuticals Corp., 247 P.3d 244 (Mont. 2010). [read post]
12 Sep 2008, 2:33 pm
: (IP finance), MARQUES international advertising portal goes live: (Class 46) Global - Patents Using patent landscaping analytics to improve the quality of M & A decisions: a review of Cox Enterprises’ $300M purchase of Adify: (IP Asset Maximiser Blog), Universities reap royalty rewards; investors ignore IP at their peril: (IAM), Top IP-owning nations claim faster patent processing; near harmonisation deal: (Intellectual Property Watch), Bosch, Xerox and Dupont sign up… [read post]
9 Oct 2019, 3:23 pm
Notably, CMS and OIG propose to expressly exclude, or are seeking comments regarding whether to exclude, certain entities from participating in protected arrangements on the basis of historical enforcement and oversight experience: (i) pharmaceutical manufacturers; (ii) manufacturers, distributors, or suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS); (iii) laboratories; (iv) pharmacy benefit managers; and (v) other wholesalers and distributors. [read post]
17 Oct 2009, 12:00 am
The article tries to draw the border between the relevant choice-of-law rules. [read post]
9 Aug 2011, 4:30 am
Mayo v. [read post]
1 Jul 2012, 2:54 am
J 0009/11 This concerned a situation where the applicant tried to pay the extension fees late. [read post]
27 Mar 2023, 9:01 pm
Note, however, that this figure does not include class action suits filed in state court or state court derivative suits, including those in the Delaware Court of Chancery. [read post]
5 Jul 2008, 11:05 am
, (Daily Dose of IP), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South Africa): (Afro-IP), 15-16 September: US ACI 10th advanced forum on biotech… [read post]
4 Dec 2009, 5:00 am
We tried to think of a great issue to explore today - and struck out. [read post]
12 Jan 2010, 5:00 am
Novartis Pharmaceuticals Corp., No. [read post]
25 Jan 2019, 9:57 am
M.H. v. [read post]
